Transarterial Ethanol Ablation(TEA) for Unresectable Hepatocellular Carcinoma(HCC)

Clinical trial NCT01837381 · COMPLETED

Trial details

NCT number: NCT01837381
Sponsor: Chinese University of Hong Kong
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Hepatocellular Carcinoma

Start date: 2007-02-01
Primary completion: 2017-07-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.